Advanced search
Publication Cover
Ophthalmic Epidemiology Volume 28, 2021 - Issue 1
Submit an article Journal homepage
365
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Real-World Visual and Neovascularisation Outcomes from anti-VEGF in Central Retinal Vein Occlusion

H. D. Jeffry Hogga Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK;b The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8044-7790
ORCID Icon,
S. James Talksb The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UKORCID Iconhttps://orcid.org/0000-0001-6126-6476
ORCID Icon,
Mark Pearcea Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UKORCID Iconhttps://orcid.org/0000-0002-0583-3779
ORCID Icon &
Sandro Di Simpliciob The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UKORCID Iconhttps://orcid.org/0000-0001-5114-3843
ORCID Icon
Pages 70-76 | Received 31 Oct 2019, Accepted 30 Jun 2020, Published online: 12 Jul 2020

References

  • Rogers S, McIntosh RL, Cheung N, et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmol. 2010;117(2):313–319.e311. doi:10.1016/j.ophtha.2009.07.017.
  • Iijima H. Mechanisms of vision loss in eyes with macular edema associated with retinal vein occlusion. Jpn J Ophthalmol. 2018;62(3):265–273. doi:10.1007/s10384-018-0586-5.
  • Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol. 1994;117(4):429–441. doi:10.1016/S0002-9394(14)70001-7.
  • A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion: the central vein occlusion study group N report. Ophthalmol. 1995;102(10):1434–1444. doi:10.1016/S0161-6420(95)30848-2.
  • National Institute for Health and Care Excellence. Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion; 2013.
  • National Institute for Health and Care Excellence. Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion; 2014.
  • Hykin P, Scott IU. New clinical trial results in retinal vein occlusion: SCORE2 and LEAVO trials. The Association for Research in Vision and Ophthalmology annual meeting; 2019; Vancouver, Canada.
  • Clinical Trial Register. A Multicentre Phase III Double-masked Randomised Controlled Non-Inferiority Trial comparing the clinical and cost effectiveness of intravitreal therapy with ranibizumab (Lucentis) vs aflibercept (Eylea) vs bevacizumab (Avastin) for Macular Oedema due to Central Retinal Vein Occlusion (CRVO); 2014.
  • Hayreh SS, Bridget Zimmerman M. Ocular neovascularization associated with central and hemicentral retinal vein occlusion. Retina. 2012;32(8):1553–1565. doi:10.1097/IAE.0b013e318246912c.
  • Brown DM, Wykoff CC, Wong TP, Mariani AF, Croft DE, Schuetzle KL. Ranibizumab in preproliferative (ischemic) central retinal vein occlusion: the rubeosis anti-VEGF (RAVE) trial. Retina. 2014;34(9):1728–1735. doi:10.1097/IAE.0000000000000191.
  • Brown DM, Campochiaro PA, Singh RP, et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmol. 2010;117(6):1124–1133.e1121. doi:10.1016/j.ophtha.2010.02.022.
  • Heier JS, Campochiaro PA, Yau L, et al. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. Ophthalmol. 2012;119(4):802–809. doi:10.1016/j.ophtha.2011.12.005.
  • Campochiaro PA, Sophie R, Pearlman J, et al. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study. Ophthalmol. 2014;121(1):209–219. doi:10.1016/j.ophtha.2013.08.038.
  • Chatziralli I, Theodossiadis G, Chatzirallis A, Parikakis E, Mitropoulos P, Theodossiadis P. Ranibizumab for retinal vein occlusion: predictive factors and long-term outcomes in real-life data. Retina. 2018;38(3):559–568. doi:10.1097/IAE.0000000000001579.
  • Yanagida C, Muramatsu D, Wakabayashi Y, et al. Long-term outcome of intravitreal aflibercept for macular edema secondary to central retinal vein occlusion. Jap J Clin Ophthalmol. 2017;71(3):439–444.
  • Hogg HJ, Di Simplicio S, Pearce MS. Ranibizumab and aflibercept intravitreal injection for treatment naive and refractory macular oedema in branch retinal vein occlusion. Eur J Ophthalmol. 2020;1120672120904669.
  • Campochiaro PA, Hafiz G, Mir TA, et al. Scatter photocoagulation does not reduce macular edema or treatment burden in patients with retinal vein occlusion: the RELATE trial. Ophthalmol. 2015;122(7):1426–1437. doi:10.1016/j.ophtha.2015.04.006.
  • Hayreh SS, Podhajsky PA, Zimmerman MB. Natural history of visual outcome in central retinal vein occlusion. Ophthalmol. 2011;118(1):119–133.e112. doi:10.1016/j.ophtha.2010.04.019.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.